Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H21N3OS.ClH |
| Molecular Weight | 327.873 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC1=CC=C(CN(CCN(C)C)C2=NC=CS2)C=C1
InChI
InChIKey=GSDXPNOJFAITBE-UHFFFAOYSA-N
InChI=1S/C15H21N3OS.ClH/c1-17(2)9-10-18(15-16-8-11-20-15)12-13-4-6-14(19-3)7-5-13;/h4-8,11H,9-10,12H2,1-3H3;1H
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C15H21N3OS |
| Molecular Weight | 291.412 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17719807
Eight female pigs were anaesthetized byinitially intramuscular injection of a 1 ml mixture con-sisting of zolamine 5 mg/ml, butorphanol 1 mg/ml,ketamine 10 mg/ml and xylazin 2 mg/ml, followedby continuous intravenous infusion of propofol10 mg/kg per hour and fentanyl 0.025 mg/kg perhour throughout the operation.
Route of Administration:
Intramuscular
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:46:05 GMT 2025
by
admin
on
Mon Mar 31 17:46:05 GMT 2025
|
| Record UNII |
C2B9CF1640
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 310.201
Created by
admin on Mon Mar 31 17:46:05 GMT 2025 , Edited by admin on Mon Mar 31 17:46:05 GMT 2025
|
||
|
NCI_THESAURUS |
C29578
Created by
admin on Mon Mar 31 17:46:05 GMT 2025 , Edited by admin on Mon Mar 31 17:46:05 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C81149
Created by
admin on Mon Mar 31 17:46:05 GMT 2025 , Edited by admin on Mon Mar 31 17:46:05 GMT 2025
|
PRIMARY | |||
|
m539
Created by
admin on Mon Mar 31 17:46:05 GMT 2025 , Edited by admin on Mon Mar 31 17:46:05 GMT 2025
|
PRIMARY | Merck Index | ||
|
300000055472
Created by
admin on Mon Mar 31 17:46:05 GMT 2025 , Edited by admin on Mon Mar 31 17:46:05 GMT 2025
|
PRIMARY | |||
|
14386
Created by
admin on Mon Mar 31 17:46:05 GMT 2025 , Edited by admin on Mon Mar 31 17:46:05 GMT 2025
|
PRIMARY | |||
|
1155-03-9
Created by
admin on Mon Mar 31 17:46:05 GMT 2025 , Edited by admin on Mon Mar 31 17:46:05 GMT 2025
|
PRIMARY | |||
|
C2B9CF1640
Created by
admin on Mon Mar 31 17:46:05 GMT 2025 , Edited by admin on Mon Mar 31 17:46:05 GMT 2025
|
PRIMARY | |||
|
CHEMBL127453
Created by
admin on Mon Mar 31 17:46:05 GMT 2025 , Edited by admin on Mon Mar 31 17:46:05 GMT 2025
|
PRIMARY | |||
|
DTXSID70151119
Created by
admin on Mon Mar 31 17:46:05 GMT 2025 , Edited by admin on Mon Mar 31 17:46:05 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |